Ravi Salgia to Anticarcinogenic Agents
This is a "connection" page, showing publications Ravi Salgia has written about Anticarcinogenic Agents.
Connection Strength
0.409
-
Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP. Mol Carcinog. 2021 03; 60(3):213-223.
Score: 0.189
-
Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice. Mol Carcinog. 2019 08; 58(8):1438-1449.
Score: 0.167
-
Role of receptor tyrosine kinases in lung cancer. Methods Mol Med. 2003; 74:113-25.
Score: 0.054